Abstract Background Intrathecal IgM synthesis has been identified as an adverse prognostic
factor in patients with multiple sclerosis (MS); however, some studies have not confirmed this …

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous
system (CNS) caused by complex gene-environment interactions. ATXN1 maps to 6p22. 3 …

Abstract Background Intrathecal IgM synthesis demonstrated either as cerebrospinal fluid
(CSF)-restricted oligoclonal (o-) IgM bands or calculated using various formulas has been …

Background An association has been found between the presence of lipid‐specific
oligoclonal IgM bands (LS‐OCMB) in cerebrospinal fluid and a more severe clinical multiple …

Background Large-scale disease overarching longitudinal data are rare in the field of
neuroimmunology. However, such data could aid early disease stratification, understanding …

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the
central nervous system (CNS). It is estimated that more than 2 million people worldwide …

Bei der Multiplen Sklerose ist die frühe Diagnose und Prognoseabschätzung eine wichtige
Voraussetzung für eine möglichst frühe und gezielte effektive Therapie. Auch wenn kein …

Bei der Multiplen Sklerose (MS) handelt es sich um eine chronisch-entzündliche,
demyelinisierende Erkrankung des zentralen Nervensystems. Sie stellt die häufigste …

La esclerosis múltiple (EM) es una enfermedad inflamatoria desmielinizante crónica del
sistema nervioso central (SNC), que afecta en la mayoría de los casos a adultos jóvenes, y …

Multiple sclerosis (MS) is a heterogeneous disease, differing on many variables, including
disease course, sex, and overall activity. Key characteristics of the disease encompass …